These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18569404)

  • 1. Akathisia in adults with severe and profound intellectual disability: a psychometric study of the MEDS and ARMS.
    Garcia MJ; Matson JL
    J Intellect Dev Disabil; 2008 Jun; 33(2):171-6. PubMed ID: 18569404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The convergent and divergent validity of the Matson Evaluation of Drug Side-effects (MEDS) and the Dyskinesia Identification System: Condensed User Scale (DISCUS).
    Matson JL; Fodstad JC; Rivet TT
    J Intellect Dev Disabil; 2008 Dec; 33(4):337-44. PubMed ID: 19039694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akathisia in adults with mental retardation: development of the Akathisia Ratings of Movement Scale (ARMS).
    Bodfish JW; Newell KM; Sprague RL; Harper VN; Lewis MH
    Am J Ment Retard; 1997 Jan; 101(4):413-23. PubMed ID: 9017087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case study of neuroleptic-induced akathisia: important implications for individuals with mental retardation.
    Gross EJ; Hull HG; Lytton GJ; Hill JA; Piersel WC
    Am J Ment Retard; 1993 Jul; 98(1):156-64. PubMed ID: 8103997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders.
    Kim JH; Jung HY; Kang UG; Jeong SH; Ahn YM; Byun HJ; Ha KS; Kim YS
    Mov Disord; 2002 Nov; 17(6):1354-9. PubMed ID: 12465082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic-induced acute and chronic akathisia: a clinical comparison.
    Kim JH; Jin YH; Kang UG; Ahn YM; Ha KS; Kim YS
    Mov Disord; 2005 Dec; 20(12):1667-70. PubMed ID: 16078203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Examination of Psychotropic Medication Side Effects: does taking a greater number of psychotropic medications from different classes affect presentation of side effects in adults with ID?
    Mahan S; Holloway J; Bamburg JW; Hess JA; Fodstad JC; Matson JL
    Res Dev Disabil; 2010; 31(6):1561-9. PubMed ID: 20542660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of social and adaptive skills in adults with bipolar disorder and severe/profound intellectual disability.
    Matson JL; Terlonge C; González ML; Rivet T
    Res Dev Disabil; 2006; 27(6):681-7. PubMed ID: 16343842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic drug side effects for persons with intellectual disability.
    Matson JL; Mahan S
    Res Dev Disabil; 2010; 31(6):1570-6. PubMed ID: 20580203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutoff scores for the Matson Evaluation of Social Skills for Individuals With Severe Retardation (MESSIER) for adults with intellectual disability.
    Matson JL; Boisjoli JA
    Behav Modif; 2008 Jan; 32(1):109-20. PubMed ID: 18096974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actometry and Barnes Akathisia Rating Scale in neuroleptic-induced akathisia.
    Janno S; Holi MM; Tuisku K; Wahlbeck K
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):39-41. PubMed ID: 15572272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akathisia--diagnostic dilemma and behavioral treatment.
    Mattoo SK; Singh G; Vikas A
    Neurol India; 2003 Jun; 51(2):254-6. PubMed ID: 14571019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side effect profiles of atypical antipsychotics, typical antipsychotics, or no psychotropic medications in persons with mental retardation.
    Advokat CD; Mayville EA; Matson JL
    Res Dev Disabil; 2000; 21(1):75-84. PubMed ID: 10750167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the Interact Short Form as a tool to evaluate emotion of people with profound intellectual disabilities.
    Liu KP; Lee T; Yan A; Siu CW; Choy FW; Leung KL; Siu TY; Kwan AC
    J Intellect Disabil Res; 2007 Nov; 51(Pt 11):884-91. PubMed ID: 17910540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Drug-Associated Extrapyramidal Symptoms in People With Intellectual Disability: A Comparison of an Informant-Based Scale With Clinical Rating Scales.
    de Kuijper GM; Hoekstra PJ
    J Clin Psychopharmacol; 2016 Oct; 36(5):508-12. PubMed ID: 27529770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ComFor: an instrument for the indication of augmentative communication in people with autism and intellectual disability.
    Noens I; van Berckelaer-Onnes I; Verpoorten R; van Duijn G
    J Intellect Disabil Res; 2006 Sep; 50(Pt 9):621-32. PubMed ID: 16901289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes to Sexuality Questionnaire (Individuals with an Intellectual Disability): scale development and community norms.
    Cuskelly M; Gilmore L
    J Intellect Dev Disabil; 2007 Sep; 32(3):214-21. PubMed ID: 17885900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of carbamazepine against neuroleptic-induced akathisia in treatment with perospirone: case series.
    Masui T; Kusumi I; Takahashi Y; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):343-6. PubMed ID: 15694245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akathisia masked by hypokinesia.
    Tuisku K; Lauerma H; Holi MM; Honkonen T; Rimon R
    Pharmacopsychiatry; 2000 Jul; 33(4):147-9. PubMed ID: 10958265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic withdrawal-induced relapse predicts future relapses in institutionalized adults with severe intellectual disability.
    Janowsky DS; Barnhill LJ; Khalid AS; Davis JM
    J Clin Psychopharmacol; 2008 Aug; 28(4):401-5. PubMed ID: 18626266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.